Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antroquinonol in Stage IV Non-Squamous NSCLC
NCT02047344Phase 2Completed
- Sponsor
- Golden Biotechnology Corporation
- Start
- Oct 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of antroquinonol in non-small cell lung cancer (NSCLC), sponsored by Golden Biotechnology Corporation. Started Oct 2013; status: completed.
02
Drugs
antroquinonol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02047344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047344.